6
total announcements
524768.BO · 15 min delayed
Emmessar Biotech & Nutrition Ltd
Emmessar Biotech & Nutrition Ltd has announced a newspaper advertisement for its 34th Annual General Meeting (AGM) to be held on September 29, 2026, through video conferencing.
Emmessar Biotech & Nutrition Ltd
Emmessar Biotech & Nutrition Ltd has announced its unaudited consolidated financial results for the quarter ended June 30, 2026, showing a net profit of Rs. 629.49 lakhs and a total income from operations of Rs. 4,277.16 lakhs.
Emmessar Biotech & Nutrition Ltd
Emmessar Biotech & Nutrition Ltd has announced its unaudited financial results for the quarter ended June 30, 2026. The company has provided the facility for shareholders to exercise their right to vote at the Annual General Meeting (AGM) by electronic means. The results have been reviewed by the Audit Committee and approved by the Board of Directors.
Emmessar Biotech & Nutrition Ltd
Emmessar Biotech & Nutrition Ltd announced unaudited financial results for the quarter ended June 30, 2026, with the Board of Directors approving the results and the Audit Committee reviewing them. The company will hold its 34th Annual General Meeting through video conferencing, with e-voting facilities available for members.
Emmessar Biotech & Nutrition Ltd
Emmessar Biotech & Nutrition Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 07/08/2026 to consider and approve unaudited Financial Results for the quarter ended June 30, 2026.
Emmessar Biotech & Nutrition Ltd
Emmessar Biotech & Nutrition Ltd has published a newspaper advertisement informing shareholders regarding the special window for re-lodgement of transfer requests of physical shares, as per SEBI Circulars.